ICCT Stock Overview
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
iCoreConnect Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.10 |
52 Week High | US$20.70 |
52 Week Low | US$0.91 |
Beta | 0.63 |
1 Month Change | -8.75% |
3 Month Change | -39.84% |
1 Year Change | -89.51% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -89.01% |
Recent News & Updates
Recent updates
Shareholder Returns
ICCT | US Healthcare Services | US Market | |
---|---|---|---|
7D | -6.4% | -0.8% | 1.0% |
1Y | -89.5% | -9.6% | 21.9% |
Return vs Industry: ICCT underperformed the US Healthcare Services industry which returned -9.6% over the past year.
Return vs Market: ICCT underperformed the US Market which returned 21.9% over the past year.
Price Volatility
ICCT volatility | |
---|---|
ICCT Average Weekly Movement | 18.3% |
Healthcare Services Industry Average Movement | 9.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ICCT's share price has been volatile over the past 3 months.
Volatility Over Time: ICCT's weekly volatility has decreased from 46% to 18% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 69 | Robert McDermott | www.icoreconnect.com |
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services.
iCoreConnect Inc. Fundamentals Summary
ICCT fundamental statistics | |
---|---|
Market cap | US$11.12m |
Earnings (TTM) | -US$15.92m |
Revenue (TTM) | US$8.15m |
1.4x
P/S Ratio-0.7x
P/E RatioIs ICCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ICCT income statement (TTM) | |
---|---|
Revenue | US$8.15m |
Cost of Revenue | US$2.03m |
Gross Profit | US$6.12m |
Other Expenses | US$22.04m |
Earnings | -US$15.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.57 |
Gross Margin | 75.11% |
Net Profit Margin | -195.30% |
Debt/Equity Ratio | 138.2% |
How did ICCT perform over the long term?
See historical performance and comparison